| Viatris Pharma GmbH - Arixtra 1.5 mg/0.3 ml, Injektionslösung |
| 55937 | | 02 | | Arixtra 1.5 mg/0.3 ml | | Injektionslösung | | B01AX05 | | Fondaparinux | | 17.12.2004 | | |
|
| Composition |
| fondaparinuxum natricum 1.5 mg, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Fondaparinuxum Natricum | 1.5mg / 0.3ml |
| | BAG: Active Agent | Dose |
|---|
| Fondaparinuxum Natricum | 1.5 mg |
| | | | Inactive agents |
|---|
| Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 040 | 10 syringe(s) | 19.76 | 37.90 | B | SL | Yes |
|
